BioVie Inc. (BIVI): Price and Financial Metrics
BIVI Price/Volume Stats
| Current price | $3.36 | 52-week high | $58.20 |
| Prev. close | $3.51 | 52-week low | $1.04 |
| Day low | $3.32 | Volume | 1,527,300 |
| Day high | $3.62 | Avg. volume | 1,687,727 |
| 50-day MA | $2.28 | Dividend yield | N/A |
| 200-day MA | $4.63 | Market Cap | 31.37M |
BIVI Stock Price Chart Interactive Chart >
BioVie Inc. (BIVI) Company Bio
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. It develops BIV201, which completed Phase 2a clinical trial for the treatment of ascites due to chronic liver cirrhosis. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was founded in 2013 and is based in Santa Monica, California.
BIVI Price Returns
| 1-mo | 0.00% |
| 3-mo | 4.02% |
| 6-mo | -26.02% |
| 1-year | -93.09% |
| 3-year | -94.36% |
| 5-year | N/A |
| YTD | -73.33% |
| 2023 | -83.78% |
| 2022 | 72.67% |
| 2021 | -74.02% |
| 2020 | 394.86% |
| 2019 | N/A |
Loading social stream, please wait...